Mauro Esteves Hernandes
Overview
Explore the profile of Mauro Esteves Hernandes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maia I, Biasi Cavalcanti A, Tramujas L, Veiga V, Oliveira J, Sady E, et al.
Br J Anaesth
. 2024 Nov;
134(3):693-702.
PMID: 39592365
Background: This study aimed to assess whether a driving pressure-limiting strategy based on positive end-expiratory pressure (PEEP) titration according to best respiratory system compliance and tidal volume adjustment increases the...
2.
Maia I, Medrado Jr F, Tramujas L, Tomazini B, Oliveira J, Sady E, et al.
Crit Care Sci
. 2024 May;
36:e20240210en.
PMID: 38775567
Background: Driving pressure has been suggested to be the main driver of ventilator-induced lung injury and mortality in observational studies of acute respiratory distress syndrome. Whether a driving pressure-limiting strategy...
3.
de Barros E Silva P, Furtado R, de Alcantara Chaud M, Macedo A, Bronhara B, Damiani L, et al.
J Thromb Thrombolysis
. 2024 May;
57(6):1031-1039.
PMID: 38762708
Therapeutic anticoagulation showed inconsistent results in hospitalized patients with COVID-19 and selection of the best patients to use this strategy still a challenge balancing the risk of thrombotic and hemorrhagic...
4.
Albuquerque D, de Barros E Silva P, Lopes R, Hoffmann-Filho C, Nogueira P, Reis H, et al.
J Card Fail
. 2023 Aug;
30(5):639-650.
PMID: 37648061
Background: Heart failure (HF), a common cause of hospitalization, is associated with poor short-term clinical outcomes. Little is known about the long-term prognoses of patients with HF in Latin America....
5.
Avezum A, Oliveira Junior H, Neves P, Alves L, Cavalcanti A, Rosa R, et al.
EClinicalMedicine
. 2023 May;
60:102004.
PMID: 37223666
Background: COVID-19 progression is associated with an increased risk of arterial and venous thrombosis. Randomised trials have demonstrated that anticoagulants reduce the risk of thromboembolism in hospitalised patients with COVID-19,...
6.
Maia I, Marcadenti A, Zampieri F, Damiani L, Santos R, Negrelli K, et al.
Rev Bras Ter Intensiva
. 2022 Jun;
34(1):44-55.
PMID: 35766657
Repurposed drugs are important in resource-limited settings because the interventions are more rapidly available, have already been tested safely in other populations and are inexpensive. Repurposed drugs are an effective...
7.
Lopes R, de Barros E Silva P, Furtado R, Macedo A, Bronhara B, Damiani L, et al.
Lancet
. 2021 Jun;
397(10291):2253-2263.
PMID: 34097856
Background: COVID-19 is associated with a prothrombotic state leading to adverse clinical outcomes. Whether therapeutic anticoagulation improves outcomes in patients hospitalised with COVID-19 is unknown. We aimed to compare the...
8.
de Andrade P, Andrade M, Barbosa R, Labrunie A, Hernandes M, Marino R, et al.
Arq Bras Cardiol
. 2014 Jul;
102(6):566-70.
PMID: 25004418
Background: The radial access provides a lower risk of bleeding and vascular complications related to the puncture site in comparison to the femoral access. Recent studies have suggested a reduction...
9.
Machado M, Suzuki F, Mouco O, Hernandes M, Lemos M, Maia L
Arq Bras Cardiol
. 2005 Mar;
84(2):182-4.
PMID: 15761647
The assessment and stratification of patients with chest pain in the emergency unit may indicate the appropriate therapy for each patient based on the probability of the presence of acute...